The New Paper

April 15, 2021

CDC advisory panel delays Johnson and Johnson decision

A CDC advisory panel said that it needs more data before providing guidance on Johnson & Johnson’s coronavirus vaccine, delaying its recommendation by at least a week. US health officials recommended pausing use of the vaccine this week due to six reported cases of blood clotting (out of ~7M administered doses).
This story is from the April 15, 2021 edition of The New Paper – a clear, concise daily briefing that makes fact-first news easy to consume. Try it today.